Characteristics of SARS-CoV-2 patients dying in Italy Report based on available data on March 1st, 2021
Authors: Luigi Palmieri, Elvira Agazio, Xanthi Andrianou, Pierfrancesco Barbariol, Antonino Bella, Eva Benelli, Luigi Bertinato, Matilde Bocci, Stefano Boros, Giovanni Calcagnini, Marco Canevelli, Federica Censi, Alessandra Ciervo, Elisa Colaizzo, Martina Del Manso, Corrado Di Benedetto, Chiara Donfrancesco, Massimo Fabiani, et al.
Published in: Epicentro
Sample: The present report describes the characteristics of 96,149 SARS-CoV-2 patients dying in Italy*, as reported by the Integrated Covid-19 Surveillance System coordinated by the National Institute of Health-ISS. Geographic distribution across the 19 regions and 2 autonomous provinces of Trento and Bozen is presented in Table 1. Absolute number and percentage of deaths are reported according to the 3 phases that characterized the pandemic from the beginning in 2020 to the 1st of March 2021: the first wave (March-May 2020), the low incidence phase (June-September 2020), and the second wave (October 2020 – March 2021), the latter is still ongoing. The surveillance data on deaths are constantly updated and consolidated and both activities require time to be carried out. Each Region has its own organization for updating data and related execution times. Therefore, when reading the data by Region, it is necessary to take into account that the timing of notification, control, verification and updating of data varies from Region to Region and from period to period; this may involve variations (increasing and/or decreasing) and differences both with the data already published in the previous reports, and with the data published by the Civil Protection. It should also be considered that the regional differences in the percentage of deaths reported in the table should not be interpreted in terms of risk. In fact, case fatality depends on the number of infections occurring in each region over a period of time compatible with the possible observation of the fatal event. In this regard, it should also be taken into account that the difference between the number of infections and the notified cases may vary regionally and over time as a function of different test access strategies adopted during the epidemic, thus distorting the comparison of regional case fatality.